about
Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy.Fishing the targets of myeloid malignancies in the era of next generation sequencing.Treatment of acute myeloid leukemia in the next decade - Towards real-time functional testing and personalized medicine.Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.A Zebrafish Model for Evaluating the Function of Human Leukemic Gene IDH1 and Its Mutation.Efficient RNA drug delivery using red blood cell extracellular vesicles.Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
P50
Q35016157-285882BA-2F7D-486F-B323-ABDAB64D779CQ38600818-203B72BF-72EC-49FF-82DD-A3D56F68997CQ38644220-4CCB99C1-DF30-4DC9-A47D-0FBE43A66AC4Q47073200-6F72F768-AE00-4214-BF24-D26FFEB26D0BQ51426321-8D53E0EB-DF41-40BD-B4C0-D337A6216E1EQ53148068-083D40C1-DC93-427D-AED0-9D4532DCCD37Q55384966-A52054EB-CBDA-4CB2-8EE9-E1BE00AEFE5AQ90061412-5675548B-2CDC-4747-8E48-1C3B4503318D
P50
description
investigador
@es
researcher
@en
name
Bai-Liang He
@en
type
label
Bai-Liang He
@en
prefLabel
Bai-Liang He
@en
P31
P496
0000-0001-6497-884X